DMYD B — Diamyd Medical AB Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual income statement for Diamyd Medical AB, fiscal year end - August 31st, SEK millions except per share, conversion factor applied.

	2022 August 31st	2023 August 31st	2024 August 31st	2025 August 31st	2026 August 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	SAS	SAS	SAS	SAS	SAS
Status:	Final	Final	Final	Final	Preliminary
Revenue
Total Revenue	0.454	0.546	0.13	0.13	0.478
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Operating Interest Expense / Income
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	119	121	156	184	259
Operating Profit	-118	-121	-156	-184	-259
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-104	-116	-152	-170	-256
Provision for Income Taxes
Net Income After Taxes	-104	-116	-152	-170	-256
Net Income Before Extraordinary Items
Net Income	-104	-116	-152	-170	-256
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-104	-116	-152	-170	-256
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-1.31	-1.48	-1.49	-1.5	-1.75
Dividends per Share